These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A dose-ranging pharmacokinetic study of nicotine tartrate following single-dose delayed-release oral and intravenous administration. Compton RF; Sandborn WJ; Lawson GM; Sheets AJ; Mays DC; Zins BJ; Tremaine WJ; Lipsky JJ; Mahoney DW; Zinsmeister AR; Offord KP; Hurt RD; Evans BK; Green J Aliment Pharmacol Ther; 1997 Oct; 11(5):865-74. PubMed ID: 9354194 [TBL] [Abstract][Full Text] [Related]
3. Nicotine tartrate liquid enemas for mildly to moderately active left-sided ulcerative colitis unresponsive to first-line therapy: a pilot study. Sandborn WJ; Tremaine WJ; Leighton JA; Lawson GM; Zins BJ; Compton RF; Mays DC; Lipsky JJ; Batts KP; Offord KP; Hurt RD; Green J Aliment Pharmacol Ther; 1997 Aug; 11(4):663-71. PubMed ID: 9305473 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of nicotine carbomer enemas: a new treatment modality for ulcerative colitis. Green JT; Thomas GA; Rhodes J; Evans BK; Russell MA; Feyerabend C; Fuller GS; Newcombe RG; Sandborn WJ Clin Pharmacol Ther; 1997 Mar; 61(3):340-8. PubMed ID: 9084459 [TBL] [Abstract][Full Text] [Related]
5. An oral formulation of nicotine for release and absorption in the colon: its development and pharmacokinetics. Green JT; Evans BK; Rhodes J; Thomas GA; Ranshaw C; Feyerabend C; Russell MA Br J Clin Pharmacol; 1999 Oct; 48(4):485-93. PubMed ID: 10583017 [TBL] [Abstract][Full Text] [Related]
6. Nicotine carbomer enemas--pharmacokinetics of a revised formulation. Green JT; Rhodes J; Thomas GA; Evans BK; Feyerabend C; Russell MA; Sandborn WJ Ital J Gastroenterol Hepatol; 1998 Jun; 30(3):260-5. PubMed ID: 9759592 [TBL] [Abstract][Full Text] [Related]
7. Nicotine enemas for treatment of ulcerative colitis: a study of the pharmacokinetics and adverse events associated with three doses of nicotine. Ingram JR; Routledge P; Rhodes J; Marshall RW; Buss DC; Evans BK; Feyerabend C; Thomas GA Aliment Pharmacol Ther; 2004 Oct; 20(8):859-65. PubMed ID: 15479357 [TBL] [Abstract][Full Text] [Related]
8. The pharmacokinetics and colonic tissue concentrations of cyclosporine after i.v., oral, and enema administration. Sandborn WJ; Strong RM; Forland SC; Chase RE; Cutler RE J Clin Pharmacol; 1991 Jan; 31(1):76-80. PubMed ID: 2045532 [TBL] [Abstract][Full Text] [Related]
10. A placebo-controlled trial of cyclosporine enemas for mildly to moderately active left-sided ulcerative colitis. Sandborn WJ; Tremaine WJ; Schroeder KW; Batts KP; Lawson GM; Steiner BL; Harrison JM; Zinsmeister AR Gastroenterology; 1994 Jun; 106(6):1429-35. PubMed ID: 8194687 [TBL] [Abstract][Full Text] [Related]
11. Bioavailability and therapeutic activity of alicaforsen (ISIS 2302) administered as a rectal retention enema to subjects with active ulcerative colitis. Miner PB; Geary RS; Matson J; Chuang E; Xia S; Baker BF; Wedel MK Aliment Pharmacol Ther; 2006 May; 23(10):1427-34. PubMed ID: 16669957 [TBL] [Abstract][Full Text] [Related]
12. Nicotine Population Pharmacokinetics in Healthy Smokers After Intravenous, Oral, Buccal and Transdermal Administration. Olsson Gisleskog PO; Perez Ruixo JJ; Westin Å; Hansson AC; Soons PA Clin Pharmacokinet; 2021 Apr; 60(4):541-561. PubMed ID: 33354734 [TBL] [Abstract][Full Text] [Related]
13. Transdermal nicotine for mildly to moderately active ulcerative colitis. A randomized, double-blind, placebo-controlled trial. Sandborn WJ; Tremaine WJ; Offord KP; Lawson GM; Petersen BT; Batts KP; Croghan IT; Dale LC; Schroeder DR; Hurt RD Ann Intern Med; 1997 Mar; 126(5):364-71. PubMed ID: 9054280 [TBL] [Abstract][Full Text] [Related]
14. Comparison of the pharmacokinetics of an ondansetron solution (8 mg) when administered intravenously, orally, to the colon, and to the rectum. Hsyu PH; Pritchard JF; Bozigian HP; Lloyd TL; Griffin RH; Shamburek R; Krishna G; Barr WH Pharm Res; 1994 Jan; 11(1):156-9. PubMed ID: 8140047 [TBL] [Abstract][Full Text] [Related]
15. Bioavailability and absorption kinetics of nicotine following application of a transdermal system. Gupta SK; Benowitz NL; Jacob P; Rolf CN; Gorsline J Br J Clin Pharmacol; 1993 Sep; 36(3):221-7. PubMed ID: 9114908 [TBL] [Abstract][Full Text] [Related]
16. Comparative pharmacokinetics and bioavailability of tylosin tartrate and tylosin phosphate after a single oral and i.v. administration in chickens. Ji LW; Dong LL; Ji H; Feng XW; Li D; Ding RL; Jiang SX J Vet Pharmacol Ther; 2014 Jun; 37(3):312-5. PubMed ID: 24325541 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of zanamivir after intravenous, oral, inhaled or intranasal administration to healthy volunteers. Cass LM; Efthymiopoulos C; Bye A Clin Pharmacokinet; 1999; 36 Suppl 1():1-11. PubMed ID: 10429835 [TBL] [Abstract][Full Text] [Related]
18. Comparative study of enema retention and preference in ulcerative colitis. Ingram JR; Rhodes J; Evans BK; Newcombe RG; Thomas GA Postgrad Med J; 2005 Sep; 81(959):594-8. PubMed ID: 16143691 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic investigation of a nicotine sublingual tablet. Molander L; Lunell E Eur J Clin Pharmacol; 2001; 56(11):813-9. PubMed ID: 11294371 [TBL] [Abstract][Full Text] [Related]
20. 5-Aminosalicylic acid enemas in patients with active ulcerative colitis. Influence of acidity on the kinetic pattern. Bondesen S; Nielsen OH; Jacobsen O; Rasmussen SN; Hansen SH; Halskov S; Binder V; Hvidberg EF Scand J Gastroenterol; 1984 Jul; 19(5):677-82. PubMed ID: 6382570 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]